Determinants of a Subject's Decision to Participate in Clinical Anesthesia Research

被引:8
作者
Balajonda, Naraida [1 ]
Bisanar, Tiffany L. [1 ]
Mathew, Joseph P. [1 ]
Pang, Herbert [1 ]
Voils, Corrine I. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA
关键词
PREOPERATIVE ANXIETY; INFORMED-CONSENT; TRIALS; WILLINGNESS; RECRUITMENT; ENROLLMENT; ATTITUDES; HEALTH; WOMEN;
D O I
10.1213/ANE.0b013e318277dd7d
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: A top priority for research studies is to ensure that potential participants receive adequate information to make a truly informed decision. Understanding patient experiences with the recruitment process may identify areas for improvement in the consent process. We examined which factors were associated with the decision to consent in a clinical research study. METHODS: Patients scheduled for elective surgery were asked to complete a questionnaire about the consent process, immediately after being approached to participate in an anesthesia-related research study. Sociodemographic characteristics, preoperative levels of anxiety and depression, medical comorbidities, factors that may affect decision to participate in a research study, and study design features were collected. A multivariable logistic regression model was estimated to identify factors associated with providing consent. Performance of the prediction model was assessed using the receiver operating characteristic curve. Internal validity was assessed by a bootstrap analysis. RESULTS: In all, 282 participants completed the questionnaire. Of those, 179 (63%) had consented to participate in research, and 103 (37%) had declined to participate. In the multivariable logistic regression model, the odds of providing consent were higher for males (odds ratio [OR] [95% confidence interval] = 2.49 [1.29-4.79]) and for patients with higher levels of patient comfort (OR = 1.84 [1.22-2.78]). The odds of providing consent were lower for protocols that require additional testing (OR = 0.15 [0.06-0.39]) and patients with higher levels of concern about blood sampling (OR = 0.70 [0.54-0.90]) or worry about study risks (OR = 0.72 [0.55-0.95]). Bootstrap analysis revealed a stable model with high internal validity. CONCLUSIONS: The 2 strongest predictors of consent were male gender and comfort; predictors of refusal were protocol type that requires additional testing, greater concern about blood sampling and study risks, and lower overall patient comfort with the study. These patient and study characteristics may inform modification of the consent process for clinical research studies and facilitate the development of more accurate enrollment projections and strategies. (Anesth Analg 2013;116:448-54)
引用
收藏
页码:448 / 454
页数:7
相关论文
共 50 条
  • [31] Configuring the patient as clinical research subject in the UK national health service
    Adams, Mary
    McKevitt, Christopher
    ANTHROPOLOGY & MEDICINE, 2015, 22 (02) : 138 - 148
  • [32] Setting and motivation in the decision to participate: An approach to the engagement of diverse samples in mobile research
    Passmore, Susan Racine
    Casper, Erica
    Olgin, Jeffery E.
    Maguire, Carol
    Marcus, Gregory M.
    Pletcher, Mark J.
    Thomas, Stephen B.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2019, 16
  • [33] Determinants of women's decision to undergo early mammography: A survey study
    Tur-Sinai, Aviad
    Shahrabani, Shosh
    NURSING & HEALTH SCIENCES, 2020, 22 (04) : 1000 - 1009
  • [34] Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study
    Pia Dellson
    Kerstin Nilsson
    Helena Jernström
    Christina Carlsson
    Trials, 19
  • [35] A roadmap for precision medicine research recruitment: empirical assessment of the public's willingness to participate
    Moriarty, Kelsey
    Wolf, Susan M.
    Veach, Patricia M.
    LeRoy, Bonnie
    MacFarlane, Ian M.
    Zierhut, Heather A.
    PERSONALIZED MEDICINE, 2020, 17 (05) : 345 - 359
  • [36] Identifying patient values impacting the decision whether to participate in early phase clinical cancer trials: A systematic review
    van Lent, Liza G. G.
    Jabbarian, Lea J.
    Gurp, Jelle van
    Hasselaar, Jeroen
    Lolkema, Martijn P.
    van Weert, Julia C. M.
    van der Rijt, Carin C. D.
    de Jonge, Maja J. A.
    CANCER TREATMENT REVIEWS, 2021, 98
  • [37] Impact of gender on the decision to participate in a clinical trial: a cross-sectional study
    Lucas Lobato
    Jeffrey Michael Bethony
    Fernanda Bicalho Pereira
    Shannon Lee Grahek
    David Diemert
    Maria Flávia Gazzinelli
    BMC Public Health, 14
  • [38] Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study
    Dellson, Pia
    Nilsson, Kerstin
    Jernstrom, Helena
    Carlsson, Christina
    TRIALS, 2018, 19
  • [39] The Clinical Trials Nurse as Subject Advocate for Minority and Culturally Diverse Research Subjects
    Rubin, Susan L.
    JOURNAL OF TRANSCULTURAL NURSING, 2014, 25 (04) : 383 - 387
  • [40] Timing invitations to participate in clinical research: Preliminary versus informed consent
    Iltis, AS
    JOURNAL OF MEDICINE AND PHILOSOPHY, 2005, 30 (01): : 89 - 106